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Background: Thrombosis of a prosthetic valve is a serious complication in patients with pros-
theticheartvalves.Thrombolysis is the initial choiceof treatment. Patientswhodonot respond
to thrombolysis are subjected to surgery which carries a high risk. We report a case series of 5
patientswithprostheticmitralvalve thrombosiswhodidnot respondtothrombolysisandwere
subjected to percutaneous manipulation of the prosthetic valves successfully and improved.
Methods: Five patients who were diagnosed to have prosthetic mitral valve thrombosis and
failed to respond to a minimum of 36 h of thrombolysis (persistent symptoms with
increased gradients, abnormal findings on fluoroscopy),were subjected to percutaneous
treatment after receiving proper consent. None of them had a visible thrombus on trans-
thoracic echocardiogram. All patients underwent transseptal puncture following which a
6F JR4 guiding catheter was passed into the left atrium. The valve leaflets were repeatedly
hit gently under fluoroscopic guidance till they regained their normal mobility.
Results: Mean age was 38.8 years. Average peak and mean gradients prior to the procedure
were 38 and 25 and after the procedure were 12 and 6 mm of Hg respectively. All patients
had successful recovery of valve motion on fluoroscopy with normalization of gradients
and complete resolution of symptoms. None of the patients had any focal neurological
deficits, embolic manifestations or bleeding complications.
Conclusions: Percutaneous manipulation of prosthetic valves in selected patients with
prosthetic valve thrombosis who do not respond to thrombolytic therapy is feasible and
can be used as an alternative to surgery.
Copyright © 2014, Cardiological Society of India. All rights reserved.1. Introduction
Prosthetic valve thrombosis (PVT) is a rare but serious
complication of prosthetic valve replacement. It is associated
with significant morbidity and mortality. The incidence of
obstructive PVT for mechanical valves varies between 0.3%ociety of India. All rightsand 1.3% patient years.1 Surgery has been the choice of
treatment. Though Urgent surgery was not superior to fibri-
nolytic therapy at restoring valve function, it substantially
reduced the occurrence of thrombo-embolic events, major
bleeding, and recurrent PVT.2 However mortality is much
higher in patientswho are inNYHA class IV (24%) as compared
to NYHA class IeIII (4%).3 Thrombolytic therapy is beingreserved.
Fig. 1 e Passage of the 6F JR guiding catheter across the
prosthetic valve after transseptal puncture.
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who present with NYHA class III or IV symptoms or cardio-
genic shock.4 Success rates were consistently reported in the
region of 85e90%.5 Still 10e15% patients do not respond to
thrombolysis. In patients who do not respond to thrombolysis
and are being considered high risk for surgery, the treatment
options are limited. Jabbour et al reported a case of acute
prosthetic aortic valve obstruction who was treated by
percutaneous manipulation of the valve with a rigid catheter,
following which partial valve mobility was established. The
patient was subsequently treated with surgery.6
We present a case series of 5 patients who presented with
PVT and did not respond to thrombolysis. All patients were
treated subsequently by percutaneous manipulation of the
valve and improved.2. Methods
In our center all patients who present with PVT are initially
thrombolysed with prolonged infusion of either strepto-
kinase or urokinase, with serial clinical, fluoroscopic andTable 1 e Base line characteristics.
Patient Age Sex Valves Valve
involv
Mrs. S 41 F DVR
Mitral-ATS 23 mm
Aortic ATS 18 mm
Mitra
Mrs. L 38 F MVR ATS 23 mm Mitra
Mrs. LI 50 F MVR ATS 25 mm Mitra
Mrs. R 17 F MVR St. Jude's 25 mm Mitra
Mr. A 48 M DVR
Mitral St. Jude's 31 mm
Aortic Medtronic bileaflet 21 mm
Mitraechocardiographic monitoring. Patients who fail to respond
(defined as persistence of symptoms, persistence of increased
gradients across the prosthetic valve and persistence of
abnormal movement of valve leaflets on fluoroscopy in spite
of prolonged infusion of streptokinase or urokinase) are
considered for surgery. Five consecutive patients who were
diagnosed to have mitral prosthetic valve thrombosis and
failed to respond to thrombolysis were included in the study.
Our first patient was a 40 year old female who underwent a
double valve replacement in 2007. She presented to us with
acute prosthetic mitral valve thrombosis. At admission she
was in acute pulmonary edemawith hypotension. She did not
respond to thrombolysis with continuous infusion of strep-
tokinase for more than 36 h. As surgical risk was very high she
was subjected to percutaneous manipulation initially as a
bridge to further surgical management. But after percuta-
neous treatment she improved completely and did not require
any further intervention. In view of successful percutaneous
intervention we started doing the same procedure for all pa-
tients who did not respond to initial thrombolysis. Proper
informed consent was taken for all patients.3. Procedure
Through trans femoral venous route a transseptal puncture
was done with the Brockenbrough needle through 8F Mul-
lins sheath with dilator. After confirming the needle position
in the left atrium the Mullins sheath was advanced into the
left atrium. Then the needle and dilator were removed. As
soon as the dilator was removed the tip of the Mullins
sheath was positioned at the mitral prosthetic valve. A 6F
Judkins right guiding catheter was passed through the
Mullins sheath. With little manipulation the guiding cath-
eter was passed across the mitral prosthetic valve leaflet
2e3 times under fluoroscopic guidance (Fig. 1). In all the
cases the leaflet movement improved to a significant extent
after the passage of the catheter. Post procedure all patients
were continued on heparin infusion till a therapeutic INR
was achieved.4. Results
The base line characteristics are shown in Table 1. Of the five
patients there were four females. Mean age was 38.8 years.ed
Gradient
pre procedure
INR at
admission
Duration
l 35/25 mm 2.69 10 m
l 48/30 1.49 9 m 2nd episode
l 47/28 1.87 3 m
l 22/17 1.56 43 m 2nd episode
l 38/26 2.56 30 m 2nd episode
Table 2 e Pre and post procedure gradients.
Patient Gradient pre
procedure
Gradient post
procedure
Complications
1 35/25 mm 11/7 None
2 48/30 12/6 None
3 47/28 14/10 None
4 22/17 11/5 None
5 38/26 10/6 None
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aortic) and rest had only mitral valve replacement .All pa-
tients had prosthetic mitral valve thrombosis. The valve
involvedwas ATS valve (ATSMedical Inc) in 3 patients and St.
Jude valve (St. Jude Medical Inc) in the rest. Three patients
presented during the second episode of PVT and received
thrombolysis with Urokinase. The mean duration of pre-
sentation from surgery was 18 months. Average peak and
mean gradients prior to the procedure were 38 and 25 and
after the procedure were 12 and 6 mm of Hg respectively
(Table 2). All patients had successful recovery of valvemotion
on fluoroscopywith normalization of gradients and complete
resolution of symptoms. None of the patients had any focal
neurological deficits, embolic manifestations or major or
minor bleeding complications.5. Discussion
In a patientwith a prosthetic valve the classical teaching is not
to cross the prosthetic valve either with a guide wire or
catheter. But there are multiple reports which have shown
that crossing the prosthetic valve can be done safely7,8 with
the exception of few valves like the Bjork Shiley valve.9 The
potential complications thatmay be associated while crossing
a prosthetic valve include catheter or guide wire entrapment,
valve disruption, embolization etc. Embolization is a serious
complication especially in the presence of a visible thrombus.
None of our patients had a visible thrombus on transthoracic
echocardiogram at the time of procedure. Also none of them
had any complications associated with embolization. A
transesophageal echocardiographic (TEE) study would have
been more helpful but none of our patients underwent a TEE
study. All procedures have been done in patients with a
bileaflet valve at mitral position only. Whether such a proce-
dure is possible in other positions with other types of valves
needs further evaluation.6. Conclusion
Percutaneous manipulation of prosthetic valves in selected pa-
tients with prosthetic valve thrombosis who do not respond to
thrombolytic therapy is feasible and can be used as an alterna-
tive to surgery. Development of such alternative treatments is
useful especially in developing and economically backward
countries thus avoiding the higher risk and higher cost during
surgical management .Larger trials need to be done to further
confirm the safety and effectiveness of this procedure and
furtherdefinepatientsubgroupswhocanreceive this treatment.Conflicts of interest
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